Terms: = Liver cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
12 results:
1. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the kdm5a/FBP1 axis.
Yan L; Sun H; Chen Y; Yu X; Zhang J; Li P
Environ Toxicol; 2024 Jan; 39(1):341-356. PubMed ID: 37713600
[TBL] [Abstract] [Full Text] [Related]
2. Inactivation of kdm5a suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway.
Fang S; Zheng L; Shen L; Su Y; Ding J; Chen W; Chen X; Chen W; Shu G; Chen M; Zhao Z; Tu J; Ji J
Eur J Pharmacol; 2023 Feb; 940():175465. PubMed ID: 36566915
[TBL] [Abstract] [Full Text] [Related]
3. Increased Morbidity and Mortality After Hepatectomy for Colorectal liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It's Not "Just a Wedge".
Leigh N; Williams GA; Strasberg SM; Fields RC; Hawkins WG; Hammill CW; Sanford DE
Ann Surg Oncol; 2022 Sep; 29(9):5476-5485. PubMed ID: 35595939
[TBL] [Abstract] [Full Text] [Related]
4. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression.
Chen W; Zhang Q; Ding M; Yao J; Guo Y; Yan W; Yu S; Shen Q; Huang M; Zheng Y; Lin Y; Wang Y; Liu Z; Lu L
Chem Biol Interact; 2022 Apr; 356():109847. PubMed ID: 35149083
[TBL] [Abstract] [Full Text] [Related]
5. kdm5a suppresses PML-RARĪ± target gene expression and APL differentiation through repressing H3K4me2.
Xu S; Wang S; Xing S; Yu D; Rong B; Gao H; Sheng M; Tan Y; Sun X; Wang K; Xue K; Shi Z; Lan F
Blood Adv; 2021 Sep; 5(17):3241-3253. PubMed ID: 34448811
[TBL] [Abstract] [Full Text] [Related]
6. kdm5a silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D
J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431
[TBL] [Abstract] [Full Text] [Related]
7. PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome.
Tian L; Ma J; Ma L; Zheng B; Liu L; Song D; Wang Y; Zhang Z; Gao Q; Song K; Wang X
World J Surg Oncol; 2020 Nov; 18(1):303. PubMed ID: 33228682
[TBL] [Abstract] [Full Text] [Related]
8. Artificial intelligence-based framework in evaluating intrafraction motion for liver cancer robotic stereotactic body radiation therapy with fiducial tracking.
Liang Z; Zhou Q; Yang J; Zhang L; Liu D; Tu B; Zhang S
Med Phys; 2020 Nov; 47(11):5482-5489. PubMed ID: 32996131
[TBL] [Abstract] [Full Text] [Related]
9. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
10. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.
Liang J; Labadie S; Zhang B; Ortwine DF; Patel S; Vinogradova M; Kiefer JR; Mauer T; Gehling VS; Harmange JC; Cummings R; Lai T; Liao J; Zheng X; Liu Y; Gustafson A; Van der Porten E; Mao W; Liederer BM; Deshmukh G; An L; Ran Y; Classon M; Trojer P; Dragovich PS; Murray L
Bioorg Med Chem Lett; 2017 Jul; 27(13):2974-2981. PubMed ID: 28512031
[TBL] [Abstract] [Full Text] [Related]
11. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
[TBL] [Abstract] [Full Text] [Related]
12. Gamma knife surgery for brain metastasis from hepatocellular carcinoma.
Xu Q; Wu P; Feng Y; Ye K; Tong Y; Zhou Y
PLoS One; 2014; 9(2):e88317. PubMed ID: 24516635
[TBL] [Abstract] [Full Text] [Related]
